London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), announced the signing of a strategic memorandum of understanding (MOU), to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback